Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
11/2009
11/26/2009WO2009141079A1 Novel [f-18]-labelled l-glutamic acid and l-glutamine derivatives (ii), use thereof and method for their production
11/26/2009WO2009140755A1 An anti-cancer cytotoxic monoclonal antibody
11/26/2009WO2009140754A1 An anti-cancer cytotoxic monoclonal antibody
11/26/2009WO2009112823A3 Metal complexes
11/26/2009WO2009110939A9 Drug delivery system for pharmaceuticals and radiation
11/26/2009US20090291049 Targeted delivery to human diseases and disorders
11/26/2009US20090291048 Leukocyte-binding polypeptides and uses thereof
11/26/2009US20090291047 Therapy with clostridium perfringens enterotoxin to treat ovarian and uterine cancer
11/26/2009CA2724782A1 An anti-cancer cytotoxic monoclonal antibody
11/26/2009CA2723596A1 Novel [f-18]-labelled l-glutamic acid and l-glutamine derivatives (i), their use and processes for their preparation
11/26/2009CA2723594A1 {f-19}-labeled l-glutamic acid and l-glutamine derivative (iii), use thereof and method for obtaining them
11/26/2009CA2723459A1 Novel [f-18]-labelled l-glutamic acid and l-glutamine derivatives (ii), their use and processes for their preparation
11/25/2009EP2123677A1 Anti-brak (cxcl14) human monoclonal antibody and use thereof
11/25/2009EP2123621A1 New [F-18]-marked L-glutamic acids and L-glutamic acid derivatives (1), application thereof and method for their manufacture
11/25/2009EP2123620A1 {F-19}-labeled L-Glutamic acid and L-Glutamine derivative (III), use thereof and method for obtaining them
11/25/2009EP2123619A1 New [F-18]-marked L-glutamic acids and L-glutamic acid derivatives (II), application thereof and method for their manufacture
11/25/2009EP2121042A2 Compounds and methods for detection of cells
11/25/2009EP2121037A2 Imaging using radioactive monocations in combination with a receptor binding ligand that stimulates the influx of cations
11/25/2009EP1558595B1 Piperazinyl and diazapanyl benzamides and benzthioamides
11/25/2009CN101585816A Benzene sulfonamide hydroxyl derivative and intermediate thereof as well as preparation method and application thereof
11/25/2009CN101585815A Benzene sulfonic amide compound and midbody thereof as well as preparation method and application thereof
11/25/2009CN101584870A Tree polymer target contrast agent and preparation method thereof
11/24/2009US7622441 Comprising controlled substance and amino acid or polypeptide covalently bound to controlled substance in manner that renders controlled substance pharmacologically inactive; when delivered by oral route controlled substance is released in time-dependent manner by acid hydrolysis and/or enzyme cleavage
11/24/2009CA2382651C Use of simple amino acids to form porous particles
11/24/2009CA2178541C Implantable medical device
11/19/2009WO2009140599A1 Treatment of metastatic tumors
11/19/2009WO2009140383A2 Aptamers that bind to p-selectin and their use as coagulation, thrombotic, inflammatory, and metastatic disease therapeutics
11/19/2009WO2009140210A2 Radiotracers for imaging cannabinoid sub-type1 (cb1) receptor
11/19/2009WO2009139939A2 Hybrid nanoparticles as anti-cancer therapeutic agents and dual therapeutic/imaging contrast agents
11/19/2009WO2009139634A1 Radiolabelled mmp selective compounds
11/19/2009WO2009139633A1 Radiolabelled mmp selective compounds
11/19/2009WO2009077586A3 Methods and compositions for the preparation and use of toxin conjugates
11/19/2009WO2009049184A9 Systemic administration of chlorotoxin agents for the diagnosis and treatment of tumors
11/19/2009US20090286737 Erbb interface peptidomimetics and methods of use thereof
11/19/2009US20090286316 Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer
11/19/2009US20090285975 Methods for making implantable medical devices
11/19/2009US20090285756 11c/18 f-labeled inhibitors of glycogen synthase kinase-3
11/19/2009US20090285755 Methods for tumor diagnosis and therapy
11/19/2009US20090285754 Peptides for targeting apoptotic cells and uses thereof
11/19/2009US20090285753 Novel haptotactic peptides
11/19/2009US20090285752 Immunotherapy of b cell malignancies and autoimmune diseases using unconjugated antibodies and conjugated antibodies and antibody combinations and fusion proteins
11/19/2009US20090285751 Cancerous disease modifying antibodies
11/19/2009US20090285750 Agent, composition and method
11/19/2009US20090285749 Apparatus and Method for Functional Neurological Screening
11/19/2009CA2727803A1 Metal abstraction peptide (map) tag and associated methods
11/19/2009CA2724384A1 Treatment of metastatic tumors
11/18/2009EP2119690A1 Radiolabelled MMP selective compounds
11/18/2009EP2119458A1 Method for production of radiation diagnostic imaging agent
11/18/2009EP2117604A2 Methods and compositions for improved f-18 labeling of proteins, peptides and other molecules
11/18/2009EP2117600A2 Magnetic nanoparticles for the application in hyperthermia, preparation thereof and use in constructs having a pharmacological application
11/18/2009EP2117593A1 Cytotoxicity mediation of cells evidencing surface expression of cd44
11/18/2009EP1501551B1 Folate-receptor targeted imaging agents
11/18/2009EP0957901B1 Pharmaceutical preparations of glutathione and methods of administration thereof
11/18/2009CN100560549C Synthesis process of 18F labeled positive electron radioactive tracer with ionic liquid as phase transfer catalyst
11/17/2009US7618937 Macromolecular antifouling chimeric compositions or coatings comprising peptide or polypeptide anchor moiety or component coupled to peptoid or polypeptoid moiety or component; inhibits protein adsorption or cell fouling of surfaces onto which composition is coated; medical devices; inhibits biofouling
11/17/2009US7618641 Functionally reconstituted viral membranes containing adjuvant
11/17/2009US7618613 Method for radiolabeling antibodies with yttrium-90
11/17/2009CA2157577C Growth differentiation factor-8
11/12/2009WO2009137649A2 Methods for treating thyroid cancer
11/12/2009WO2009137428A2 Methods of determining renal function using technetium-99m tricarbonyl-nitrilotriacetic acid
11/12/2009WO2009135627A1 Use of a radioactively labelled molecule specifically binding to ed-b fibronectin in a method of hodgkin lymphoma
11/12/2009WO2009087066A3 Method for preparing a marked purine derivative, said derivative and uses thereof
11/12/2009US20090280503 Method for detecting and treating skin disorders
11/12/2009US20090280120 Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies
11/12/2009US20090280059 Substituted aryl piperidinylalkynyladenosines as a2ar agonists
11/12/2009US20090280058 Delivery Of Double-Stranded RNA Into The Central Nervous System
11/12/2009US20090280057 Combination of Intercalating Organometallic Complexes and Tumor Seeking Biomolecules for DNA Cleavage and Radiotherapy
11/12/2009US20090280056 Antibodies and immunoconjugates and uses therefor
11/12/2009US20090280055 Use of Fluorine-Containing Compounds for Diagnostic Purposes Using Imaging Methods
11/12/2009CA2723323A1 Use of a radioactively labelled molecule specifically binding to ed-b fibronectin in a method of treatment of hodgkin lymphoma
11/11/2009EP2116555A1 Use of a radioactively labelled molecule specifically binding to ED-B fibronectin in a method of treatment of Hodgkin lymphoma
11/11/2009EP2115177A1 Method for the elution of 18f fluoride trapped on an anion-exchange phase in a form suitable for efficient radiolabeling without any evaporation step
11/11/2009EP2114873A2 Ligands for imaging cardiac innervation
11/11/2009EP2114464A2 Radiofluorination methods
11/11/2009EP2114461A2 Diagnostic and therapeutic cyclooxygenase-2 binding ligands
11/11/2009EP1928508B1 Biotin diaminoderivatives and their conjugates with macrocyclic chelating agents
11/11/2009EP1482795B1 New immunoeffector compounds
11/11/2009EP1317278B1 Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom
11/11/2009CN101575355A Tc marked daunorubicin dithiocarbamate composition and preparation method and applications thereof
11/11/2009CN101574532A Targeted Claudin-4 developer without influence on permeability between epithelial cells
11/11/2009CN101574531A TcO nucleus marked ciprofloxacin dithiocarbamate complex and preparation method and applications thereof
11/11/2009CN100558718C Piperazinyl and diazapanyl benzamides and benzthioamides
11/10/2009US7615567 Such as 2-exo-[5'-(3'-Amino-2'-fluoropyridinyl)]-7-azabicyclo[2.2.1]-heptane; Tourette's syndrome
11/10/2009US7615208 Administering a radionuclide-labeled bis-aminoethanethiol (BAT) tetradentate targeting ligand conjugate, which is a folate receptor targeting ligand, an agent that mimics glucose, annexin V, colchicine, glutamate pentapeptide, or a tumor hypoxia targeting ligand
11/10/2009US7615207 Methods for treating irritable bowel syndrome
11/05/2009WO2009135015A2 Improved methods and compositions for f-18 labeling of proteins, peptides and other molecules
11/05/2009WO2009134405A2 Novel substrate based pet imaging agents
11/05/2009WO2009133362A2 Agents for detecting and imaging cell death
11/05/2009WO2008075040A3 Radioactive pet agents for imaging ccr5 in vivo
11/05/2009WO2008064040A3 Methods and compositions using chelator-antibody conjugates
11/05/2009US20090274649 Bispecific Antibody Point Mutations for Enhancing Rate of Clearance
11/05/2009US20090274624 Radiotracers for imaging p-glycoprotein function
11/05/2009US20090274623 In vivo imaging agents for met receptor tyrosine kinase
11/05/2009US20090274622 Necrosis avid tracer agent
11/05/2009US20090274621 Use of pyrene to carry non-peptide agents across the blood brain barrier
11/05/2009US20090274620 Hybridoma Cell Line G250 and its use for Producing Monoclonal Antibodies
11/05/2009US20090274619 Tumor vasculature markers and methods of use therof
11/05/2009US20090274618 TADG-15: an extracellular serine protease overexpressed in carcinomas
11/05/2009DE102009019474A1 Mittel und Verfahren zur Modulation der Radioaktivität eines lebenden Körpers Means and methods for modulation of the radio activity of a living body
11/05/2009CA2722914A1 Agents for detecting and imaging cell death
1 ... 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 ... 243